The breast cancer molecular subtypes were distributed as follows: triple negative (31.3%), luminal A (25.4%), luminal B Her2- (21.6%), luminal B Her2+ (11%) and Her2 (10.7%) (Fig. 1B). This evidence concerns the gene ERBB2 and breast cancer.